Targeted Therapies in Oncology: The Role of Ceritinib Capsules 150mg and Other Innovations
Amongst thrombopoietin receptor agonists, Avatrombopag tablets 20mg, Cabozantinib tablets 20mg, Eltrombopag 25mg, and Eltrombopag 50mg tablets stand out for their usage in chronic ITP and liver disease-associated thrombocytopenia. For ALK-positive NSCLC, Crizotinib capsules offer first-line alternatives, while Finerenone 10mg tablets provide an one